Zuzana Diamant to Humans
This is a "connection" page, showing publications Zuzana Diamant has written about Humans.
Connection Strength
0.067
-
Revisiting matrix metalloproteinase 12: its role in pathophysiology of asthma and related pulmonary diseases. Curr Opin Pulm Med. 2021 01; 27(1):54-60.
Score: 0.007
-
COVID-19, chronic inflammatory respiratory diseases and eosinophils-Observations from reported clinical case series. Allergy. 2020 07; 75(7):1819-1822.
Score: 0.007
-
Precision medicine and treatable traits in chronic airway diseases - where do we stand? Curr Opin Pulm Med. 2020 01; 26(1):33-39.
Score: 0.007
-
Much ado about Biologicals: Highlights of the Master Class on Biologicals, Prague, 2018. Allergy. 2019 04; 74(4):837-840.
Score: 0.006
-
Toward effective prescription of inhaled corticosteroids in chronic airway disease. Int J Chron Obstruct Pulmon Dis. 2018; 13:3419-3424.
Score: 0.006
-
Sputum induction with hypertonic saline reduces fractional exhaled nitric oxide in chronic smokers and non-smokers. Respir Med. 2010 Jun; 104(6):917-20.
Score: 0.003
-
Summing up 100 years of asthma. Respir Med. 2007 Mar; 101(3):378-88.
Score: 0.003
-
Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives. Allergy. 2021 06; 76(6):1640-1660.
Score: 0.002
-
Immune Profile in Patients With COVID-19: Lymphocytes Exhaustion Markers in Relationship to Clinical Outcome. Front Cell Infect Microbiol. 2021; 11:646688.
Score: 0.002
-
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper. Allergy. 2021 03; 76(3):648-676.
Score: 0.002
-
PDE3-inhibitor enoximone prevented mechanical ventilation in patients with SARS-CoV-2 pneumonia. Exp Lung Res. 2021 04; 47(3):149-160.
Score: 0.002
-
Asthma and severe acute respiratory syndrome coronavirus 2019: current evidence and knowledge gaps. Curr Opin Pulm Med. 2021 01; 27(1):45-53.
Score: 0.002
-
A compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy. 2020 10; 75(10):2503-2541.
Score: 0.002
-
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions. Eur Respir J. 2019 09; 54(3).
Score: 0.002
-
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper. Allergy. 2019 03; 74(3):432-448.
Score: 0.002
-
Personalized Approach to Severe Asthma. Biomed Res Int. 2018; 2018:2465172.
Score: 0.002
-
ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing. Eur Respir J. 2018 11; 52(5).
Score: 0.002
-
Towards precision medicine in severe asthma: Treatment algorithms based on treatable traits. Respir Med. 2018 09; 142:15-22.
Score: 0.002
-
Targeting the interleukin-4 and interleukin-13 pathways in severe asthma: current knowledge and future needs. Curr Opin Pulm Med. 2018 01; 24(1):50-55.
Score: 0.001
-
Assessing patient-reported outcomes in asthma and COPD patients: which can be recommended in clinical practice? Curr Opin Pulm Med. 2018 01; 24(1):18-23.
Score: 0.001
-
Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implications. Allergy. 2018 04; 73(4):837-850.
Score: 0.001
-
Club cell protein (CC16) in plasma, bronchial brushes, BAL and urine following an inhaled allergen challenge in allergic asthmatics. Biomarkers. 2018 Feb; 23(1):51-60.
Score: 0.001
-
Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled study. J Allergy Clin Immunol. 2018 04; 141(4):1220-1230.
Score: 0.001